Curis DSO Ratio 2011-2026 | CRIS

Annual DSO Ratio Curis

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	103	105	111	107	106	118	100	113	119	97.6	72.7	35.9	19.5	1.04

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
119	1.04	86.5

Quarterly DSO Ratio Curis

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
86.1	84.1	109	-	86	84.2	108	-	84.3	97.6	105	-	46.6	39.3	117	-	80.1	91	109	91.8	101	118	106	90.1	104	141	158	94.9	91.8	111	110	86	115	136	118	95	128	134	121	91.9	94	92.3	112	89.8	101	37.3	122	88.4	18.7	24.9	125	49.1	143	19	4.19	0.27	26.1	9.77	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
158	0.27	89.4

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Regeneron Pharmaceuticals REGN	152	$ 742.1	-1.93 %	$ 77.6 B	USA
AbbVie ABBV	258	$ 211.9	0.37 %	$ 375 B	USA
AbCellera Biologics ABCL	173	$ 3.28	-2.24 %	$ 980 M	Canada
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Rigel Pharmaceuticals RIGL	57.9	$ 26.28	-0.34 %	$ 473 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Avidity Biosciences RNA	45.1	$ 13.07	-0.23 %	$ 1.8 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Rhythm Pharmaceuticals RYTM	42.9	$ 77.56	-5.31 %	$ 5.04 B	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	60.7	$ 12.27	-12.11 %	$ 1.86 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
SIGA Technologies SIGA	47.1	$ 5.36	7.96 %	$ 383 M	USA
SELLAS Life Sciences Group SLS	72	$ 4.47	-9.69 %	$ 487 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Summit Therapeutics SMMT	379	$ 16.59	-3.88 %	$ 12.4 B	Britain